Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.
Human Skeletal Muscle Myoblasts (HSMM) derived from quadricep biopsy (Lonza, catalog #CC-2580, lot #257130) were expanded in 10% FBS SkGM-2 (Lonza).  All procedures have been performed using HSMM within P10 from explant.